Pharmacological Activation of Nrf2 Enhances Functional Liver Regeneration

Benjamin K.Y. Chan, Mohamed Elmasry, Shiva S. Forootan, Giusy Russomanno, Tobias M. Bunday, Fang Zhang, Nathalie Brillant, Philip J. Starkey Lewis, Rhona Aird, Emanuele Ricci, Timothy D. Andrews, Rowena L. Sison‐Young, Amy L. Schofield, Yongxiang Fang, Adam Lister, Jack W. Sharkey, Harish Poptani, Neil R. Kitteringham, Stuart J. Forbes, Hassan Z. Malik, Stephen W. Fenwick, B. Kevin Park, Christopher E. Goldring, Ian M. Copple – 18 April 2021

Applying Administrative Data‐Based Coding Algorithms for Frailty in Patients With Cirrhosis

Jeremy Louissaint, Susan L. Murphy, Christopher J. Sonnenday, Anna S. Lok, Elliot B. Tapper – 18 April 2021 – Frailty is a powerful prognostic tool in cirrhosis. Claims‐based frailty scores estimate the presence of frailty without the need for in‐person evaluation. These algorithms have not been validated in cirrhosis. Whether they measure true frailty or perform as well as frailty in outcome prediction is unknown.

Efficacy and Safety of Endoscopic Balloon Placement for Weight Loss in Patients With Cirrhosis Awaiting Liver Transplantation

Kymberly D. Watt, Julie K. Heimbach, Monika Rizk, Pete Jaruvongvanich, William Sanchez, John Port, Sudhakar K. Venkatesh, Heather Bamlet, Kathryn Tiedtke, Harmeet Malhi, Andres Acosta Cardenas, Karen Grothe, Matthew Clark, Manpreet S. Mundi, Barham K. Abu Dayyeh – 17 April 2021 – The efficacy and safety of a fluid‐filled intragastric balloon (IGB) for weight loss in patients with cirrhosis on the liver transplantation (LT) waiting list is unknown.

Subscribe to